EAN 2026 | Genetic pathways associated with body-first and brain-first Parkinson’s disease
Massimiliano Passaretti
• 28 Jun 2026
Massimiliano Passaretti, MD, PhD, Karolinska Institute, Solna, Sweden, discusses the genetic pathways associated with body-first and brain-first Parkinson’s disease. Dr Passaretti highlights that a better understanding of these genetic differences can improve patient stratification and support the development of more personalized treatment approaches. This interview took place at the 12th Congress of the European Academy of Neurology (EAN) in Geneva, Switzerland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
